CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
4.150
+0.180 (4.53%)
At close: Nov 25, 2025, 4:00 PM EST
4.240
+0.090 (2.17%)
Pre-market: Nov 26, 2025, 5:15 AM EST
CytomX Therapeutics Employees
As of December 31, 2024, CytomX Therapeutics had 121 total employees, including 119 full-time and 2 part-time employees. The number of employees decreased by 1 or -0.82% compared to the previous year.
Employees
121
Change (1Y)
-1
Growth (1Y)
-0.82%
Revenue / Employee
$939,099
Profits / Employee
$231,554
Market Cap
703.16M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 121 | -1 | -0.82% |
| Dec 31, 2023 | 122 | 4 | 3.39% |
| Dec 31, 2022 | 118 | -60 | -33.71% |
| Dec 31, 2021 | 178 | 32 | 21.92% |
| Dec 31, 2020 | 146 | -14 | -8.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CTMX News
- 21 hours ago - CytomX Therapeutics to Present at Upcoming December Investor Conferences - GlobeNewsWire
- 7 days ago - CytomX Therapeutics: Leaning Into The Hype, But What's Next? - Seeking Alpha
- 12 days ago - CytomX Therapeutics to Present at the Jefferies London Healthcare Conference - GlobeNewsWire
- 15 days ago - Targeting Adhesion Molecules With ADC's: The Bet Of CytomX - Seeking Alpha
- 18 days ago - CytomX Therapeutics, Inc. (CTMX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - CytomX Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 21 days ago - Top Biotech Stocks Riding The Rally - Seeking Alpha
- 21 days ago - CytomX Therapeutics to Present CX-801 Phase 1 Monotherapy Biomarker Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting - GlobeNewsWire